Stocks · Korea 338840 KOSDAQ

Y-Biologics

8,180원 -3.54% Market cap 1,260억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR4.67x
EPS0 KRW
BPS1,752 KRW
ROE-198.34%
DPS0 KRW

Returns and 52-week range

1W+1.49%
1M-3.31%
3M-30.32%
6M-74.56%
1Y-43.08%
YTD-62.39%
52W high38,000원
52W low7,230원
From 52W high-78.47%

Financial results (separate)

PeriodRevenueOperating incomeNet incomeOP margin
202335억-101억-209억-291.5%
202458억-84억-64억-146.6%
202529억-93억-420억-318.2%
Quarterly
2024 4Q11억-24억-18억-205.8%
2025 1Q4억-23억-19억-554.6%
2025 2Q12억-15억-23억-128.4%
2025 3Q9억-25억-27억-283.5%
2025 4Q4억-30억-351억-665.5%
2026 1Q3억-39억-43억-1,376.4%

Company

CEO박영우, 박범찬(각자대표)
Founded2007-12-31
Fiscal year end12
Address: 대전광역시 유성구 테크로 4로 17, 비715호

Peers in the same sector

CompanyMarket capP/EP/B1M
성도이엔지1,273억4.220.43+20.89%
바이젠셀1,209억—2.77-5.75%
고려신용정보1,300억9.562.06+0.99%
제일파마홀딩스1,208억7.930.36-1.18%
메쎄이상1,303억8.261.61-5.78%
NICE인프라1,118억14.000.54-5.48%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.